US Broker Ratings

AdaptHealth Corp. (AHCO) Investor Outlook: Analyzing a 34.25% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector, operates within the medical devices industry, specializing in the distribution of home medical equipment and supplies across the United..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring 26% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the medical care facilities industry, is attracting attention from investors with its potential upside of 26.42%. As of now, the..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 195% Upside Amidst Challenging Financials

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, operates in the diagnostics and pharmaceuticals industries, catering to a diverse market spanning the United States, Europe, and..

Pulse Biosciences, Inc (PLSE): Investor Outlook with a 44.64% Potential Upside

Pulse Biosciences, Inc. (NASDAQ: PLSE), a burgeoning entity in the healthcare sector, is making waves with its innovative approach to medical instruments and supplies. With a market capitalization of $1.02..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Uncovering a Potential 148% Upside in Biotech Innovation

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, is making waves in the healthcare sector with its cutting-edge RNA medicines platform, PRISM. Despite recent challenges, the company’s innovative..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Unveiling a 106% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a dynamic player in the healthcare sector, is making waves in the biopharmaceutical landscape with its promising vaccine portfolio. Headquartered in Emeryville, California, Dynavax is..

Indivior PLC (INDV) Stock Analysis: Evaluating Growth Potential with a 11.18% Upside

Indivior PLC (INDV), a prominent player in the healthcare sector, specializing in drug manufacturing, particularly in the realm of opioid dependence treatment, presents an intriguing opportunity for investors. With its..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Unveiling a 40% Upside Potential

U.S. Physical Therapy, Inc. (NYSE: USPH) is gaining traction among investors, buoyed by a promising 40.71% potential upside according to analyst consensus. This Houston-based company, specializing in outpatient physical therapy..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: 12.49% Potential Upside Captivates Investors

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotechnology firm focused on autoimmune diseases, presents a compelling opportunity for investors with its innovative therapies and promising financial metrics. As of the..

Evolent Health (EVH) Stock Analysis: Exploring a 58% Upside Potential Amidst Healthcare Sector Challenges

Evolent Health, Inc (NYSE: EVH) stands as a key player in the health information services industry, offering an integrated platform for health plan administration and value-based business infrastructure. With its..

Phreesia, Inc. (PHR) Stock Analysis: A 18.74% Potential Upside in the Health Information Services Sector

Phreesia, Inc. (NYSE: PHR) is garnering the attention of investors with its promising 18.74% potential upside, according to analyst ratings. As a key player in the healthcare sector’s information services..

AtriCure, Inc. (ATRC) Stock Analysis: Healthcare Innovator with a 50% Upside Potential

AtriCure, Inc. (NASDAQ: ATRC), a leading player in the healthcare sector, specializes in the development and sale of advanced medical devices for cardiac surgery. With a market capitalization of $1.64..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A Potential 121.97% Upside in Rare Disease Innovation

For investors exploring opportunities in the biotechnology sector, Viridian Therapeutics, Inc. (NASDAQ: VRDN) presents an intriguing prospect. With a market cap of $1.41 billion, this U.S.-based company is carving a..

Biohaven Ltd. (BHVN) Stock Analysis: A 315% Potential Upside in Biotech Investment

For investors with an appetite for high-risk, high-reward opportunities, Biohaven Ltd. (NASDAQ: BHVN) presents a compelling case. The biotechnology company, headquartered in New Haven, Connecticut, is making waves in the..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unraveling a 44.78% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents a compelling case for investors seeking potential growth..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a Potential 100% Upside in the Healthcare Sector

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, has garnered significant attention from investors, particularly due to its potential upside of over 100%. With a market..

Progyny, Inc. (PGNY) Stock Analysis: Unpacking the 15% Upside Potential and Analyst Consensus

Progyny, Inc. (NASDAQ: PGNY) stands as a beacon of innovation within the healthcare sector, particularly in the niche of fertility and women’s health benefits. Headquartered in New York, the company’s..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring the 112% Potential Upside in Biotech

For investors with an eye on the biotechnology sector, Centessa Pharmaceuticals plc (NASDAQ: CNTA) presents an intriguing opportunity. Headquartered in Altrincham, United Kingdom, Centessa is a clinical-stage pharmaceutical company focused..

The Pennant Group, Inc. (PNTG) Stock Analysis: A 44.7% Upside Potential in the Healthcare Sector

For investors looking to explore opportunities within the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents a compelling case. With a focus on home health, hospice, and senior living..

Integra LifeSciences Holdings C (IART) Stock Analysis: Exploring a 21% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Integra LifeSciences Holdings Corporation (NASDAQ: IART) presents a potentially intriguing option, offering a glimpse into the world of medical devices with a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds